Medical Disclaimer: Retatrutide is an investigational compound and is not FDA-approved
Sometimes missed doses reveal obstaclesfear of needles, side effect concerns, or confusion about injection techniquethat deserve direct support rather than silent struggle
This includes individuals with: Diagnosed MASLD or MASH, where GLP-1 therapy may offer therapeutic benefits but requires monitoring Chronic viral hepatitis (hepatitis B or C), particularly if transaminases are elevated Autoimmune hepatitis or other inflammatory liver conditions Cirrhosis or advanced fibrosis, where specialist consultation may be appropriate despite generally not requiring dose adjustment History of drug-induced liver injury from other agents For these patients, baseline comprehensive liver assessmentincluding liver enzymes, synthetic function tests (albumin, INR), and potentially imaging or non-invasive fibrosis markers (such as FIB-4 or ELF)helps establish a reference point for monitoring treatment effects
2026 regulatory note: Compounded GLP-1 medications are not FDA-approved finished drug products
How to Know if Tirzepatide Could Be Right for You: Tirzepatide is believed to be potentially better at assisting weight loss than semaglutide
Mattison McGee Lost over 60 lbs *Personal results may vary based on our individualized health programs